Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skystone Advisors was a Boston-based investment management firm and hedge fund that specialized in the healthcare and life sciences sectors. Founded by Nelson Saiers, a former Deutsche Bank proprietary trader with a PhD in mathematics, the firm was known for its quantitative and data-driven approach to biotech investing. While active, Skystone managed significant assets and was a frequent participant in both public equity markets and private financing rounds for emerging biotechnology companies. The firm gained attention for its focus on volatility and complex market dynamics within the healthcare space. Following the founder's transition into a career as a professional artist, the firm ceased its primary investment operations and is no longer considered an active entity in the current biotechnology investment landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skystone Advisors.